Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 112

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

Passaquin, Anne-Catherine, Renard, Mathilde, Kay, Laurence, Challet, Corinne, Mokhtarian, Armand, Wallimann, Theo, Ruegg, Urs T.·2002·Neuromuscular Disorders

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0960-8966(01)00273-5

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 36

  1. Emery, 1991, Population frequencies of inherited neuromuscular diseases – a world survey, Neuromuscul Disord, 1, 19, 10.1016/0960-8966(91)90039-U · DOI · Paper page
  2. Gillis, 1999, Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse, J Muscle Res Cell Motil, 20, 605, 10.1023/A:1005545325254 · DOI
  3. Sicinski, 1989, The molecular basis of muscular dystrophy in the mdx mouse: a point mutation, Science, 244, 1578, 10.1126/science.2662404 · DOI · Paper page
  4. Ohlendieck, 1991, Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle, FEBS Lett, 283, 230, 10.1016/0014-5793(91)80595-T · DOI
  5. Campbell, 1995, Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage, Cell, 80, 675, 10.1016/0092-8674(95)90344-5 · DOI · Paper page
  6. Ruegg, 1999, Calcium homeostasis in dystrophic muscle, Trends Pharmacol Sci, 20, 351, 10.1016/S0165-6147(99)01377-2 · DOI
  7. Kuznetsov, 1998, Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse, Mol Cell Biochem, 183, 87, 10.1023/A:1006868130002 · DOI
  8. Buetler, 2001, Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species, Am J Clin Nutr.
  9. Dubrovsky, 1998, Steroids in muscular dystrophy: where do we stand?, Neuromuscul Disord, 8, 380, 10.1016/S0960-8966(98)00047-9 · DOI
  10. Passaquin, 1993, Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse, J Neurosci Res, 35, 363, 10.1002/jnr.490350403 · DOI
  11. Leijendekker, 1996, Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress, Br J Pharmacol, 118, 611, 10.1111/j.1476-5381.1996.tb15445.x · DOI
  12. Passaquin, 1998, Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells, Br J Pharmacol, 124, 1751, 10.1038/sj.bjp.0702036 · DOI
  13. Pulido, 1998, Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells, FEBS Lett, 439, 357, 10.1016/S0014-5793(98)01399-4 · DOI
  14. Fitch, 1964, A study of creatine metabolism in diseases causing muscle wasting, J Clin Invest, 43, 444, 10.1172/JCI104929 · DOI
  15. Wallimann, 1992, Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis, Biochem J, 281, 21, 10.1042/bj2810021 · DOI · Paper page
  16. Klivenyi, 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nat Med, 5, 347, 10.1038/6568 · DOI · Paper page
  17. Sullivan, 2000, Dietary supplement creatine protects against traumatic brain injury, Ann Neurol, 48, 723, 10.1002/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W · DOI
  18. Dangott, 2000, Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy, Int J Sports Med, 21, 13, 10.1055/s-2000-8848 · DOI
  19. Kay, 2000, Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in muscle cells in situ, J Biol Chem, 275, 6937, 10.1074/jbc.275.10.6937 · DOI · Paper page
  20. Veksler, 1987, Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers, Biochim Biophys Acta, 892, 191, 10.1016/0005-2728(87)90174-5 · DOI · Paper page
  21. Carnwath, 1987, Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles, J Neurol Sci, 80, 39, 10.1016/0022-510X(87)90219-X · DOI · Paper page
  22. Karpati, 1986, Small caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression, Am J Med Genet, 25, 653, 10.1002/ajmg.1320250407 · DOI
  23. Deconinck, 1997, Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice, Nat Med, 3, 1216, 10.1038/nm1197-1216 · DOI
  24. Dangain, 1984, Muscle development in mdx mutant mice, Muscle Nerve, 7, 700, 10.1002/mus.880070903 · DOI · Paper page
  25. Ikejima, 1997, Kupffer cells contain a glycine-gated chloride channel, Am J Physiol, 272, G1581
  26. Thurman, 1997, Prevention of cyclosporine-induced nephrotoxicity with dietary glycine, Transplantation, 63, 1661, 10.1097/00007890-199706150-00021 · DOI
  27. Rossi, 1990, Muscle-type MM creatine kinase is specifically bound to sarcoplasmic reticulum and can support Ca2+ uptake and regulate local ATP/ADP ratios, J Biol Chem, 265, 5258, 10.1016/S0021-9258(19)34115-8 · DOI
  28. Korge, 1993, Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca2+-ATPase, Eur J Biochem, 213, 973, 10.1111/j.1432-1033.1993.tb17842.x · DOI
  29. Steeghs, 1997, Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies, Cell, 89, 93, 10.1016/S0092-8674(00)80186-5 · DOI · Paper page
  30. Nicolas-Metral, 2001, Mdx myotubes have normal excitability but show reduced contraction–relaxation dynamics, J Muscle Res Cell Motil, 22, 69, 10.1023/A:1010384625954 · DOI
  31. van Leemputte, 1999, Shortening of muscle relaxation time after creatine loading, J Appl Physiol, 86, 840, 10.1152/jappl.1999.86.3.840 · DOI
  32. Schlattner, 1998, Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach, Mol Cell Biochem, 184, 125, 10.1023/A:1006851330913 · DOI
  33. Beutner, 1996, Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore, FEBS Lett, 396, 189, 10.1016/0014-5793(96)01092-7 · DOI · Paper page
  34. O'Gorman, 1997, The role of creatine kinase in inhibition of mitochondrial permeability transition, FEBS Lett, 414, 253, 10.1016/S0014-5793(97)01045-4 · DOI · Paper page
  35. Tarnopolsky, 2001, Creatine transporter and mitochondrial creatine kinase protein content in myopathies: significant reduction of creatine transporters in myopathies, Muscle Nerve, 10.1002/mus.1055 · DOI · Paper page
  36. McIntosh, 1998, Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair, NMR Biomed, 11, 1, 10.1002/(SICI)1099-1492(199802)11:1<1::AID-NBM493>3.0.CO;2-D · DOI

Cited by

See all 112

Metadata

Authors
Passaquin, A.-C., Renard, M., Kay, L., Challet, C., Mokhtarian, A., Wallimann, T., & Ruegg, U. T.
Venue
Neuromuscular Disorders
Publisher
Elsevier BV
Published
2002-02
Volume
12
Issue
2
Pages
174-182
ISSN
0960-8966
Cited by
112
References
6
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. https://app.cochat.ai/papers/10.1016/s0960-8966(01)00273-5
The paper
Passaquin, A.-C., Renard, M., Kay, L., Challet, C., Mokhtarian, A., Wallimann, T., & Ruegg, U. T. (2002). Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscular Disorders. https://doi.org/10.1016/s0960-8966(01)00273-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.